* iSpecimen Inc ISPC.OQ ISPC.O is expected to show a
fall in
quarterly revenue when it reports results
* The Lexington Massachusetts-based company is expected to
report
a 13.5% decrease in revenue to $2.235 million from $2.58
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for iSpecimen Inc is
for a
loss of 35 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for iSpecimen
Inc is
$5, above its last closing price of $0.64.
This summary was machine generated October 31 at 18:51 GMT. All
figures in US dollars unless otherwise stated